The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Trastuzumab-Global Market Insights and Sales Trends 2025
Synopsis
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
The global Trastuzumab market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Trastuzumab in various end use industries. The expanding demands from the Hospital and Medical Center, are propelling Trastuzumab market. Human Source, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Source segment is estimated at % CAGR for the next seven-year period.
Trastuzumab is a monoclonal antibody used in breast cancer therapy. Market trends include the expansion of its use in adjuvant and neoadjuvant settings, as well as research into biosimilars to improve affordability and accessibility.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Trastuzumab, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Trastuzumab market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Trastuzumab market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Trastuzumab sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Trastuzumab covered in this report include Genentech Inc, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc.
The global Trastuzumab market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Global Trastuzumab market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Trastuzumab market, Segment by Type:
Human Source
Animal Source
Global Trastuzumab market, by Application
Hospital
Medical Center
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Trastuzumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Trastuzumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Trastuzumab, a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
The global Trastuzumab market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Trastuzumab in various end use industries. The expanding demands from the Hospital and Medical Center, are propelling Trastuzumab market. Human Source, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Source segment is estimated at % CAGR for the next seven-year period.
Trastuzumab is a monoclonal antibody used in breast cancer therapy. Market trends include the expansion of its use in adjuvant and neoadjuvant settings, as well as research into biosimilars to improve affordability and accessibility.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Trastuzumab, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Trastuzumab market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Trastuzumab market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Trastuzumab sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Trastuzumab covered in this report include Genentech Inc, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc.
The global Trastuzumab market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Global Trastuzumab market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Trastuzumab market, Segment by Type:
Human Source
Animal Source
Global Trastuzumab market, by Application
Hospital
Medical Center
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Trastuzumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Trastuzumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Trastuzumab Market Overview
1.1 Trastuzumab Product Overview
1.2 Trastuzumab Market Segment by Type
1.2.1 Human Source
1.2.2 Animal Source
1.3 Global Trastuzumab Market Size by Type
1.3.1 Global Trastuzumab Market Size Overview by Type (2018-2029)
1.3.2 Global Trastuzumab Historic Market Size Review by Type (2018-2023)
1.3.3 Global Trastuzumab Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Trastuzumab Sales Breakdown by Type (2018-2023)
1.4.2 Europe Trastuzumab Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Trastuzumab Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Trastuzumab Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Trastuzumab Sales Breakdown by Type (2018-2023)
2 Global Trastuzumab Market Competition by Company
2.1 Global Top Players by Trastuzumab Sales (2018-2023)
2.2 Global Top Players by Trastuzumab Revenue (2018-2023)
2.3 Global Top Players by Trastuzumab Price (2018-2023)
2.4 Global Top Manufacturers Trastuzumab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Trastuzumab Market Competitive Situation and Trends
2.5.1 Trastuzumab Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Trastuzumab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Trastuzumab as of 2022)
2.7 Date of Key Manufacturers Enter into Trastuzumab Market
2.8 Key Manufacturers Trastuzumab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Trastuzumab Status and Outlook by Region
3.1 Global Trastuzumab Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Trastuzumab Historic Market Size by Region
3.2.1 Global Trastuzumab Sales in Volume by Region (2018-2023)
3.2.2 Global Trastuzumab Sales in Value by Region (2018-2023)
3.2.3 Global Trastuzumab Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Trastuzumab Forecasted Market Size by Region
3.3.1 Global Trastuzumab Sales in Volume by Region (2024-2029)
3.3.2 Global Trastuzumab Sales in Value by Region (2024-2029)
3.3.3 Global Trastuzumab Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Trastuzumab by Application
4.1 Trastuzumab Market Segment by Application
4.1.1 Hospital
4.1.2 Medical Center
4.2 Global Trastuzumab Market Size by Application
4.2.1 Global Trastuzumab Market Size Overview by Application (2018-2029)
4.2.2 Global Trastuzumab Historic Market Size Review by Application (2018-2023)
4.2.3 Global Trastuzumab Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Trastuzumab Sales Breakdown by Application (2018-2023)
4.3.2 Europe Trastuzumab Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Trastuzumab Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Trastuzumab Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Trastuzumab Sales Breakdown by Application (2018-2023)
5 North America Trastuzumab by Country
5.1 North America Trastuzumab Historic Market Size by Country
5.1.1 North America Trastuzumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Trastuzumab Sales in Volume by Country (2018-2023)
5.1.3 North America Trastuzumab Sales in Value by Country (2018-2023)
5.2 North America Trastuzumab Forecasted Market Size by Country
5.2.1 North America Trastuzumab Sales in Volume by Country (2024-2029)
5.2.2 North America Trastuzumab Sales in Value by Country (2024-2029)
6 Europe Trastuzumab by Country
6.1 Europe Trastuzumab Historic Market Size by Country
6.1.1 Europe Trastuzumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Trastuzumab Sales in Volume by Country (2018-2023)
6.1.3 Europe Trastuzumab Sales in Value by Country (2018-2023)
6.2 Europe Trastuzumab Forecasted Market Size by Country
6.2.1 Europe Trastuzumab Sales in Volume by Country (2024-2029)
6.2.2 Europe Trastuzumab Sales in Value by Country (2024-2029)
7 Asia-Pacific Trastuzumab by Region
7.1 Asia-Pacific Trastuzumab Historic Market Size by Region
7.1.1 Asia-Pacific Trastuzumab Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Trastuzumab Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Trastuzumab Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Trastuzumab Forecasted Market Size by Region
7.2.1 Asia-Pacific Trastuzumab Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Trastuzumab Sales in Value by Region (2024-2029)
8 Latin America Trastuzumab by Country
8.1 Latin America Trastuzumab Historic Market Size by Country
8.1.1 Latin America Trastuzumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Trastuzumab Sales in Volume by Country (2018-2023)
8.1.3 Latin America Trastuzumab Sales in Value by Country (2018-2023)
8.2 Latin America Trastuzumab Forecasted Market Size by Country
8.2.1 Latin America Trastuzumab Sales in Volume by Country (2024-2029)
8.2.2 Latin America Trastuzumab Sales in Value by Country (2024-2029)
9 Middle East and Africa Trastuzumab by Country
9.1 Middle East and Africa Trastuzumab Historic Market Size by Country
9.1.1 Middle East and Africa Trastuzumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Trastuzumab Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Trastuzumab Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Trastuzumab Forecasted Market Size by Country
9.2.1 Middle East and Africa Trastuzumab Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Trastuzumab Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Genentech Inc
10.1.1 Genentech Inc Company Information
10.1.2 Genentech Inc Introduction and Business Overview
10.1.3 Genentech Inc Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Genentech Inc Trastuzumab Products Offered
10.1.5 Genentech Inc Recent Development
10.2 Novartis AG
10.2.1 Novartis AG Company Information
10.2.2 Novartis AG Introduction and Business Overview
10.2.3 Novartis AG Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis AG Trastuzumab Products Offered
10.2.5 Novartis AG Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Trastuzumab Products Offered
10.3.5 Pfizer Recent Development
10.4 Abnova Corporation
10.4.1 Abnova Corporation Company Information
10.4.2 Abnova Corporation Introduction and Business Overview
10.4.3 Abnova Corporation Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abnova Corporation Trastuzumab Products Offered
10.4.5 Abnova Corporation Recent Development
10.5 InvivoGen
10.5.1 InvivoGen Company Information
10.5.2 InvivoGen Introduction and Business Overview
10.5.3 InvivoGen Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.5.4 InvivoGen Trastuzumab Products Offered
10.5.5 InvivoGen Recent Development
10.6 Celltrion
10.6.1 Celltrion Company Information
10.6.2 Celltrion Introduction and Business Overview
10.6.3 Celltrion Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Celltrion Trastuzumab Products Offered
10.6.5 Celltrion Recent Development
10.7 Biocon Limited
10.7.1 Biocon Limited Company Information
10.7.2 Biocon Limited Introduction and Business Overview
10.7.3 Biocon Limited Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biocon Limited Trastuzumab Products Offered
10.7.5 Biocon Limited Recent Development
10.8 Bio-Techne
10.8.1 Bio-Techne Company Information
10.8.2 Bio-Techne Introduction and Business Overview
10.8.3 Bio-Techne Trastuzumab Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bio-Techne Trastuzumab Products Offered
10.8.5 Bio-Techne Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Trastuzumab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Trastuzumab Industrial Chain Analysis
11.4 Trastuzumab Market Dynamics
11.4.1 Trastuzumab Industry Trends
11.4.2 Trastuzumab Market Drivers
11.4.3 Trastuzumab Market Challenges
11.4.4 Trastuzumab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Trastuzumab Distributors
12.3 Trastuzumab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
